FibroGen Inc (NAS:FGEN)
$ 1.1609 -0.0291 (-2.45%) Market Cap: 115.48 Mil Enterprise Value: 90.73 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 56/100

Q3 2019 FibroGen Inc Earnings Call Transcript

Nov 11, 2019 / 10:00PM GMT
Release Date Price: $35.4 (-14.94%)
Operator

Welcome to the FibroGen Third Quarter 2019 Financial Results Conference Call. My name is Erin, and I'll be your operator for today's call.

(Operator Instructions) Please note that this conference is being recorded. I will now turn the call over to Michael Tung. Michael, you may begin.

Michael Tung

Thank you, Erin, and good afternoon, everyone. Thank you for joining our call. Today, we'll be reporting financial results and corporate updates for the third quarter of 2019. Joining me today on the call are Jim Schoeneck, Interim Chief Executive Officer; Dr. Peony Yu, Chief Medical Officer; Ms. Chris Chung, Senior Vice President, China; Dr. Elias Kouchakji, Senior Vice President, Clinical Development and Drug Safety and Pharmacovigilance; and Mr. Pat Cotroneo, Chief Financial Officer.

Following our prepared remarks, Jim will discuss upcoming milestones, and we will then open the call to Q&A. During this call, we may make forward-looking statements regarding our business, including our collaborations with AstraZeneca and Astellas; financial guidance

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot